Moderna COVID Vaccine Technology Struck Down by PTABModerna's COVID-19 vaccine patents faced invalidation due to claims of being overly broad and prior knowledge of key vaccine concepts.
Summer COVID Wave Prompts Early Emergency Approval of New VaccinesThe FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.
Moderna COVID Vaccine Technology Struck Down by PTABModerna's COVID-19 vaccine patents faced invalidation due to claims of being overly broad and prior knowledge of key vaccine concepts.
Summer COVID Wave Prompts Early Emergency Approval of New VaccinesThe FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.
Vaccine for winter vomiting bug to be trialled on thousandsA new norovirus vaccine trial aims to protect vulnerable populations and reduce healthcare system burdens during winter months.
Doctors trial world's first vaccine against vomiting bug norovirusA groundbreaking clinical trial is underway for the world's first norovirus vaccine, aimed at reducing health and economic tolls linked to the virus.
Vaccine for winter vomiting bug to be trialled on thousandsA new norovirus vaccine trial aims to protect vulnerable populations and reduce healthcare system burdens during winter months.
Doctors trial world's first vaccine against vomiting bug norovirusA groundbreaking clinical trial is underway for the world's first norovirus vaccine, aimed at reducing health and economic tolls linked to the virus.
Two-in-one flu and Covid jab passes advanced trialModerna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.
US prepares for bird flu pandemic with $176M Moderna vaccine dealThe US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.
As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccineThe US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.
Northwestern University Sues Moderna Over Spikevax VaccineNorthwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.
Two-in-one flu and Covid jab passes advanced trialModerna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.
US prepares for bird flu pandemic with $176M Moderna vaccine dealThe US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.
As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccineThe US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.
Northwestern University Sues Moderna Over Spikevax VaccineNorthwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plansModerna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.The company faces challenges following its pandemic success, prompting a strategic shift in investment.
Cambridge-based Moderna lays out plan to slice research and development spendingModerna expects to break even by 2028, delaying its previous 2026 target due to revenue forecast disappointments.
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plansModerna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.The company faces challenges following its pandemic success, prompting a strategic shift in investment.
Cambridge-based Moderna lays out plan to slice research and development spendingModerna expects to break even by 2028, delaying its previous 2026 target due to revenue forecast disappointments.
Moderna secures a second FDA vaccine approval as Spikevax sales plummetModerna's mRESVIA vaccine approved by FDA for adults 60 and older, showing high efficacy against RSV.
An mRNA Melanoma Vaccine Shows PromiseModerna's mRNA technology shows promise in treating melanoma with positive results in a phase 2 study.
U.S. government will give Moderna $176 million to develop bird flu vaccineThe U.S. government is funding Moderna to develop a pandemic vaccine for bird flu, leveraging mRNA technology used in COVID-19 vaccines.
US Pays Moderna $176 Million to Develop Bird Flu Vaccine Amid Waves of OutbreaksModerna will use mRNA technology to develop a vaccine for the H5N1 virus, similar to the COVID-19 vaccine development.
A Combination COVID and Flu Vaccine Is Coming SoonA single vaccine from Moderna can protect against SARS-CoV-2 and influenza more effectively than separate vaccines.Moderna's mRNA-based vaccine for both SARS-CoV-2 and influenza is proven more effective in adults over 50 years old.Combination vaccines utilizing mRNA technology show promise for public health despite challenges in development costs and time.
Moderna's mRNA dreams meet reality with first post-Covid shotThe upcoming RSV shot by Moderna showcases the potential of mRNA technology to treat various illnesses beyond Covid.
US pays Moderna millions to develop bird flu jabDeveloping mRNA-based pandemic influenza vaccine to combat bird flu with US government funding.
An mRNA Melanoma Vaccine Shows PromiseModerna's mRNA technology shows promise in treating melanoma with positive results in a phase 2 study.
U.S. government will give Moderna $176 million to develop bird flu vaccineThe U.S. government is funding Moderna to develop a pandemic vaccine for bird flu, leveraging mRNA technology used in COVID-19 vaccines.
US Pays Moderna $176 Million to Develop Bird Flu Vaccine Amid Waves of OutbreaksModerna will use mRNA technology to develop a vaccine for the H5N1 virus, similar to the COVID-19 vaccine development.
A Combination COVID and Flu Vaccine Is Coming SoonA single vaccine from Moderna can protect against SARS-CoV-2 and influenza more effectively than separate vaccines.Moderna's mRNA-based vaccine for both SARS-CoV-2 and influenza is proven more effective in adults over 50 years old.Combination vaccines utilizing mRNA technology show promise for public health despite challenges in development costs and time.
Moderna's mRNA dreams meet reality with first post-Covid shotThe upcoming RSV shot by Moderna showcases the potential of mRNA technology to treat various illnesses beyond Covid.
US pays Moderna millions to develop bird flu jabDeveloping mRNA-based pandemic influenza vaccine to combat bird flu with US government funding.
I thought I had Covid - it was another, unbearably painful, disease'HIV patient contracts monkeypox, describes the painful experience.Encouraging participation in mpox vaccine trials for potential life-changing impact.
The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccineThe U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.
US Government Awards Moderna $176 Million for mRNA Bird Flu VaccineThe US government is paying Moderna $176 million to develop an mRNA vaccine against pandemic influenza amidst the spread of H5N1 in US dairy cattle.
The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccineThe U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.
US Government Awards Moderna $176 Million for mRNA Bird Flu VaccineThe US government is paying Moderna $176 million to develop an mRNA vaccine against pandemic influenza amidst the spread of H5N1 in US dairy cattle.
Moderna receives $176 million to accelerate development of pandemic bird flu vaccine as concerns growModerna receiving $176 million for pandemic flu vaccine development following bird flu outbreak.
Combined COVID-flu vaccines are coming: Moderna jab clears major testA single vaccine from Moderna protects against both SARS-CoV-2 and influenza more effectively than individual vaccines.
Moderna receives $176 million to accelerate development of pandemic bird flu vaccine as concerns growModerna receiving $176 million for pandemic flu vaccine development following bird flu outbreak.
Combined COVID-flu vaccines are coming: Moderna jab clears major testA single vaccine from Moderna protects against both SARS-CoV-2 and influenza more effectively than individual vaccines.
What to know about Moderna's combined covid-flu vaccine on the horizonModerna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.
A Combined Flu and COVID-19 Shot May Be ComingModerna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.
What to know about Moderna's combined covid-flu vaccine on the horizonModerna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.
A Combined Flu and COVID-19 Shot May Be ComingModerna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trialModerna's combo flu and COVID vaccine generates a strong immune response in older adults, potentially offering a promising solution in combating respiratory illnesses.